- Home
- IR vs STE Comparison
IR vs STE Comparison
Compare IR & STE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IR
- STE
- Stock Information
- Founded
- IR 1859
- STE 1985
- Country
- IR United States
- STE United States
- Employees
- IR N/A
- STE N/A
- Industry
- IR Industrial Machinery/Components
- STE Industrial Specialties
- Sector
- IR Industrials
- STE Health Care
- Exchange
- IR Nasdaq
- STE Nasdaq
- Market Cap
- IR 31.2B
- STE 25.9B
- IPO Year
- IR N/A
- STE 1992
- Fundamental
- Price
- IR $78.06
- STE $264.56
- Analyst Decision
- IR Buy
- STE Buy
- Analyst Count
- IR 8
- STE 9
- Target Price
- IR $94.13
- STE $268.25
- AVG Volume (30 Days)
- IR 3.7M
- STE 857.1K
- Earning Date
- IR 10-30-2025
- STE 11-05-2025
- Dividend Yield
- IR 0.10%
- STE 0.96%
- EPS Growth
- IR N/A
- STE 59.39
- EPS
- IR 1.35
- STE 6.97
- Revenue
- IR $7,458,300,000.00
- STE $5,702,415,000.00
- Revenue This Year
- IR $7.99
- STE $9.24
- Revenue Next Year
- IR $4.97
- STE $6.30
- P/E Ratio
- IR $58.08
- STE $37.72
- Revenue Growth
- IR 4.20
- STE 7.08
- 52 Week Low
- IR $65.61
- STE $200.98
- 52 Week High
- IR $106.03
- STE $268.30
- Technical
- Relative Strength Index (RSI)
- IR 53.64
- STE 66.61
- Support Level
- IR $72.45
- STE $252.15
- Resistance Level
- IR $79.40
- STE $259.01
- Average True Range (ATR)
- IR 2.08
- STE 6.00
- MACD
- IR 0.20
- STE 0.40
- Stochastic Oscillator
- IR 77.45
- STE 87.70
About IR Ingersoll Rand Inc.
Ingersoll Rand was formed through the merger of Gardner Denver and Ingersoll Rand's industrial segment. The firm's portfolio consists of two business lines: industrial technologies and services, and precision and science technologies. Ingersoll Rand serves a variety of end markets, including industrial, medical, and energy. Its broad portfolio of products includes compression, blower and vacuum, and fluid management. Ingersoll Rand generated roughly $7.2 billion in revenue in 2024.
About STE STERIS plc (Ireland)
Steris is an Ireland-domiciled medical technology company focused on sterilization services and infection prevention. The company is the global leader in contract sterilization services, ensuring the safe delivery of single-use and implantable medical equipment to hospitals around the world. Steris also sells sterilizers, washer-disinfectors, and other decontamination equipment and supplies for use by care provider facilities and in biopharma manufacturing sites. Domiciled in the United States before its inversion to Ireland, the firm derives approximately 70% of its revenue from Healthcare Services, 19% from Applied Sterilization Technologies, or AST, and 11% from life sciences services after the divestment of its dental products business.